Label: DERMAN ANTIFUNGAL- tolnaftate aerosol
- NDC Code(s): 81929-006-01
- Packager: Taisho Pharmaceutical California Inc.
- Category: HUMAN OTC DRUG LABEL
- DEA Schedule: None
Drug Label Information
Updated May 30, 2024
If you are a consumer or patient please visit this version.
- Download DRUG LABEL INFO: PDF XML
- Official Label (Printer Friendly)
- Drug Facts
- Active ingredient
- Uses
-
Warnings
For external use only
Flammable: Contents under pressure. Avoid spraying in eyes. Do not use or store near heat or open flame. Do not puncture or incinerate container. Do not store at temperature above 120ºF. Keep out of the reach of children. Use only as directed. Intentional misuse by deliberately concentrating and inhaling the contents can be harmful or fatal.
-
Directions
- wash affected area and dry thoroughly
- shake can well and spray a thin layer of the product over affected area
- twice daily (morning and night) or as directed by a doctor
- supervise children in the use of this product
- for athlete's foot: pay special attention to spaces between the toes, wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
- for athlete's foot and ringworm, use daily for 4 weeks
- if condition persists, consult a doctor
- to prevent athlete's foot: wash the feet and dry thoroughly; spray a thin layer of the product to the feet once or twice daily (morning and/or night)
- this product is not effective on the scalp or nails
- if nozzle clogs, clean with a pin
- Other information
- Inactive ingredients
- Package Labeling:
-
INGREDIENTS AND APPEARANCE
DERMAN ANTIFUNGAL
tolnaftate aerosolProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:81929-006 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TOLNAFTATE (UNII: 06KB629TKV) (TOLNAFTATE - UNII:06KB629TKV) TOLNAFTATE 10 mg in 1 g Inactive Ingredients Ingredient Name Strength BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K) ISOBUTANE (UNII: BXR49TP611) PPG-12-BUTETH-16 (UNII: 58CG7042J1) Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:81929-006-01 150 g in 1 BOTTLE, SPRAY; Type 0: Not a Combination Product 10/01/2024 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M005 10/01/2024 Labeler - Taisho Pharmaceutical California Inc. (603827635)
